RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1997; 77(03): 606-608
DOI: 10.1055/s-0038-1656017
DOI: 10.1055/s-0038-1656017
Letter to the Editor
Plasmatic Plasminogen Activator Inhibitor Activity in Patients with Primary Breast Cancer
Weitere Informationen
Publikationsverlauf
Received 16. September 1996
Accepted after revision 06. November 1996
Publikationsdatum:
11. Juli 2018 (online)
-
References
- 1 Niwano H, Takahashi H, Taewaki W, Wada K, Seki Y, Shibata A. Behaviour of tissue plasminogen activator, plasminogen activator inhibitor 1 and their complex in various disease states. Blood Coagulation and Fibrinolysis 1992; 3: 0389-0393
- 2 Pappot H, Gardsvoll H, Perdersen AN, Grondahl-Hansen J, Pyke C, Brunner N. Plasminogen Activator Inhibitor 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler 1995; 376: 0259-0269
- 3 de JongE, Knot EAR, Iburg AHC, Rijken DC, Veenhof KHN, Dooijewaard G, ten CasteJW. Increased plasminogen activator inhibition levels in malignancy. Thromb Haemost 1987; 57: 0140-0143
- 4 Newland JR, Haire WD. Elevated Plasminogen Activator Inhibitor levels found in patients with malignant conditions. Am J Clin Pathol 1991; 96: 0602-0604
- 5 Rocha E, Páramo JA, Fernández FJ, Cuesta B, Hernández M, Paloma MJ, Rifón J. Clotting activation and impairement of fibrinolysis in malignancy. Thrombosis Research 1989; 54: 0699-0707
- 6 von Tempelhoff G-F. Changes of hemorheology and clotting in different gynecologic malignancies. Clin Hemorheology 1995; 54: 0261-0262
- 7 Kwaan HC. The plasminogen-plasmin system in malignancy. Cancer and Metastasis Reviews 1992; 11: 0291-0311
- 8 Casslén B, Bossmar T, Lecander I, Astedt B. Plasminogen activators and plasminogen activator inhibitors in blood and tumor fluids of patients with ovarian cancer. Eur J Cancer 1994; 30 A: 1302-1309